Gallbladder Cancer Overview

Save information for later
Sign Up

Learn About Gallbladder Cancer

What is the definition of Gallbladder Cancer?
A benign or malignant neoplasm affecting the gallbladder. Representative examples of benign neoplasms include lipoma, leiomyoma, and neurofibroma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma.
What are the alternative names for Gallbladder Cancer?
  • Gallbladder cancer
What are the different types of Gallbladder Cancer?

Common conditions include: Gallbladder Adenocarcinoma

Who are the top Gallbladder Cancer Local Doctors?
Elite in Gallbladder Cancer
Dr. Perry Y. Shen
General Surgery | Surgical Oncology
Elite in Gallbladder Cancer
Dr. Perry Y. Shen
General Surgery | Surgical Oncology

Wake Forest University Health Sciences

Medical Ctr Blvd, 
Winston Salem, NC 
336-716-2734
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Perry Shen is a General Surgeon and a Surgical Oncologist in Winston Salem, North Carolina. Dr. Shen is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gallbladder Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Disease, Pancreatectomy, and Hepatectomy. Dr. Shen is currently accepting new patients.

Elite in Gallbladder Cancer
Dr. Claudius H. Conrad
Surgical Oncology | General Surgery
Elite in Gallbladder Cancer
Dr. Claudius H. Conrad
Surgical Oncology | General Surgery

Carle Health Care Incorporated

611 W Park St, 
Urbana, IL 
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Claudius Conrad is a Surgical Oncologist and a General Surgeon in Urbana, Illinois. Dr. Conrad is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gallbladder Cancer, Gallbladder Disease, Pancreatic Cancer, Hepatectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Conrad is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Shishir K. Maithel
Elite in Gallbladder Cancer
Dr. Shishir K. Maithel
Surgical Oncology
Elite in Gallbladder Cancer
Dr. Shishir K. Maithel
Surgical Oncology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
866-587-4322
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shishir Maithel is a Surgical Oncologist in Chicago, Illinois. Dr. Maithel has been practicing medicine for over 25 years and is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Pancreaticoduodenectomy, and Hepatectomy.

View All Doctors
What are the latest Gallbladder Cancer Clinical Trials?
Phase 1 Trial of Safety and Preliminary Efficacy of Segmental Ablative Radioembolization in Combination With Tremelimumab Plus Durvalumab (MEDI4736) in Patients With Unresectable, or Oligo-Metastatic Cholangiocarcinoma Who Are Not Candidates for Curative Therapy (RAIDEN Trial)
Phase 1 Trial of Safety and Preliminary Efficacy of Segmental Ablative Radioembolization in Combination With Tremelimumab Plus Durvalumab (MEDI4736) in Patients With Unresectable, or Oligo-Metastatic Cholangiocarcinoma Who Are Not Candidates for Curative Therapy (RAIDEN Trial)
Enrollment Status: Recruiting
Publish Date: October 10, 2025
Intervention Type: Procedure, Biological
Study Phase: Phase 1

Summary: This phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in treating patients with intrahepatic cholangiocarcinoma (cancer of the bile ducts in the liver) that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable) who are not candidates for curativ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Who is this study for: Adult patients with Metastatic or Locally Advanced Unresectable Solid Tumor or Cholangiocarcinoma or Gallbladder Carcinoma
Enrollment Status: Recruiting
Publish Date: October 10, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Avelumab, Peposertib
Study Phase: Phase 1/Phase 2

Summary: This phase I/II trial studies the best dose and side effects of peposertib and to see how well it works with avelumab and hypofractionated radiation therapy in treating patients with solid tumors and hepatobiliary malignancies that have spread to other places in the body (advanced/metastatic). Peposertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Imm...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center